Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson’s disease
Objective: To identify dopamine transporter status of corpus striatum and thalamus using magnetic resonance imaging-guided spatial normalization method in patients with PD according to olfactory…Clinical and imaging progression in the PARS cohort: Results from 6 years of observation
Objective: The goal of the Parkinson Associated Risk Syndrome (PARS) study is to explore the clinical and biomarker trajectory of individuals in the pre-motor phase…Diffusion tensor imaging of olfactory tract in Parkinson’s disease
Objective: We investigated the possible relationships among olfactory impairment and alterations in diffusion tensor imaging (DTI) of olfactory tracts, comparing a cohort of patients with…Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease
Objective: To investigate the presence of specific gender-related patterns in olfactory dysfunctions among Sardinian patients affected by Parkinson's disease (PD), compared with age and sex-matched…Asymmetric olfactory deficit in H&Y stage-1 early onset Parkinson’s disease
Objective: To determine if the olfactory deficit in the early-stage Parkinson’s disease (PD) is asymmetric between the two hemispheres ipsilateral and contralateral to the onset…Selection of odorants for diagnosis of Parkinson’s disease
Objective: The goal of this study was to identify the subset of Sniffin Sticks Test odorants that could be used to differentiate patients with Parkinson’s…Gait disturbance and olfactory dysfunction is associated with central cholinergic dysfunction in early Parkinson’s disease
Objective: We hypothesis that olfactory dysfunction, could be an independent predictor of gait disturbance in early PD. Background: The pathophysiology of gait disturbance is not fully…Progression to Parkinson’s disease in carriers of LRRK2 G2019S mutation: a 4-year prospective study with serial dopamine transporter imaging
Objective: To assess whether any of the biomarkers studied (UPDRS-III, SN echogenicity, UPSIT and DaT-SPECT) in a baseline evaluation of a cohort of LRRK2 G2019S asymptomatic…Clinical characteristics of Parkinson’s disease developed from essential tremor
Objective: The objective of this study is to compare the clinical characteristics of Parkinson’s disease developed from essential tremor (ET-PD) with the clinical characteristics of…Cardiac 123I-MIBG Scintigraphy, olfactory testing and transcranial sonography for differentiating between Parkinson’s disease and atypical parkinsonian syndromes during the early stage
Objective: To evaluate the utility of the combined use of cardiac metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS)…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 16
- Next Page »